We are live on ! Find out more
IMA

ImageneBio Inc

46 hedge funds and large institutions have $106M invested in ImageneBio Inc in 2022 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 6 increasing their positions, 19 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

0.17% less ownership

Funds ownership: 6.34%6.17% (-0.17%)

7% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 15

4% less funds holding

Funds holding: 4846 (-2)

37% less capital invested

Capital invested by funds: $168M → $106M (-$62.1M)

68% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 19

Holders
46
Holders Change
-2
Holders Change %
-4.17%
% of All Funds
0.77%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
14
Increased
6
Reduced
19
Closed
15
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
AVLSA
1
Atlas Venture Life Science Advisors
Massachusetts
$22.2M
Fidelity Investments
2
Fidelity Investments
Massachusetts
$19.5M -$1.24M -22,395 -6%
BI
3
BVF Inc
California
$11.1M +$6.9K +125 +0.1%
OFM
4
Omega Fund Management
Massachusetts
$9.96M
Citadel Advisors
5
Citadel Advisors
Florida
$9.42M -$4.14K -75 -0%
AG
6
Artal Group
Luxembourg
$6.86M
CA
7
CHI Advisors
New York
$4.83M +$1.27M +23,015 +34%
Verition Fund Management
8
Verition Fund Management
Connecticut
$4.53M +$4.7M +85,158 New
Point72 Asset Management
9
Point72 Asset Management
Connecticut
$3.05M +$1.56M +28,333 +98%
Vanguard Group
10
Vanguard Group
Pennsylvania
$2.99M -$533K -9,658 -15%
LCM
11
Laurion Capital Management
New York
$2.34M +$2.43M +44,083 New
FCM
12
Farallon Capital Management
California
$1.28M -$2.31M -41,839 -63%
BlackRock
13
BlackRock
New York
$1.27M -$5.54M -100,451 -81%
Millennium Management
14
Millennium Management
New York
$1.04M +$1.08M +19,652 New
HM
15
HealthCor Management
New York
$975K -$310K -5,628 -23%
Barclays
16
Barclays
United Kingdom
$891K -$20.7K -375 -2%
OMC
17
Oasis Management Company
Cayman Islands
$620K +$644K +11,667 New
E
18
Ergoteles
New York
$514K +$533K +9,670 New
Geode Capital Management
19
Geode Capital Management
Massachusetts
$454K -$1.04M -18,861 -69%
Ensign Peak Advisors
20
Ensign Peak Advisors
Utah
$400K -$172K -3,125 -29%
Morgan Stanley
21
Morgan Stanley
New York
$332K +$286K +5,183 +482%
State Street
22
State Street
Massachusetts
$196K -$1.66M -30,029 -89%
Jacobs Levy Equity Management
23
Jacobs Levy Equity Management
New Jersey
$181K +$188K +3,410 New
Qube Research & Technologies (QRT)
24
Qube Research & Technologies (QRT)
United Kingdom
$108K -$21.1K -383 -16%
Goldman Sachs
25
Goldman Sachs
New York
$105K -$11.8K -213 -10%

IMA Hedge Fund Activity: Q2 2022 in Review

46 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in ImageneBio Inc (IMA) for Q2 2022, worth a combined $106M — down 37% from $168M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of IMA and 14 opened new positions — a net loss of 1 holder — while 19 trimmed existing stakes and 6 added.

The largest buyer was Verition Fund Management, opening a new position worth an estimated $4.7M. The largest seller was BlackRock, cutting an estimated $5.54M.

  • 46 institutional investors held ImageneBio Inc (IMA) as of Q2 2022, down from 48 in Q1 2022.
  • Funds reported $106M of ImageneBio Inc stock for Q2 2022, down 37% quarter-over-quarter.
  • 14 funds opened new ImageneBio Inc positions in Q2 2022 and 15 closed out, a net change of -1 holder.
  • The largest ImageneBio Inc buyer in Q2 2022 was Verition Fund Management, an estimated $4.7M added.
  • The largest ImageneBio Inc seller in Q2 2022 was BlackRock, an estimated $5.54M sold.

Based on aggregated 13F filings for Q2 2022.